BIOLIFE SOLUTIONS INC (BLFS) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — BLFS

Balance Sheet

(in millions USD)

Metric	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	22.82	29.48	31.90	66.94	23.98	22.01	29.69	19.24	21.40	19.11	27.04	24.00	59.46	75.10	76.25	89.01
Accounts Receivable	13.06	10.84	10.06	9.17	17.92	18.06	18.57	24.56	26.86	30.34	32.44	31.26	24.27	20.23	21.09	10.67
Inventory	32.83	27.83	27.69	27.57	32.18	32.50	43.41	43.35	39.18	41.33	33.75	33.34	30.20	29.70	25.87	11.67
Total Current Assets	133.22	126.57	125.43	131.13	89.38	88.20	111.70	116.82	120.31	132.79	135.87	118.06	118.70	130.51	127.41	116.54
Property, Plant & Equipment	14.50	11.10	7.67	6.61	17.71	17.26	21.04	21.00	25.57	26.10	21.74	19.12	18.26	17.46	16.45	11.23
Goodwill	208.59	212.30	212.30	212.30	224.74	224.74	224.74	224.74	224.74	224.74	224.74	224.74	224.74	223.94	195.66	58.45
Intangible Assets	3.93	7.45	8.15	8.86	18.42	19.33	20.24	22.06	29.18	30.63	65.47	67.98	81.85	87.57	81.27	30.12
Total Non-current Assets*	267.68	265.52	261.81	264.01	292.27	286.78	289.90	294.33	312.87	313.68	351.81	352.32	425.31	428.89	393.56	123.48
Total Assets	400.91	392.08	387.24	395.14	381.65	374.98	401.60	411.15	433.18	446.47	487.68	470.38	544.01	559.39	520.97	240.02
Accounts Payable	3.75	2.89	3.21	3.30	3.84	4.21	4.98	11.98	10.69	15.53	13.14	11.54	11.71	14.30	9.85	4.28
Total Current Liabilities	18.25	27.15	28.31	27.72	32.17	30.82	38.66	42.62	39.59	47.32	36.95	33.30	35.04	35.79	31.28	16.38
Long-term Debt	2.50	7.49	10.05	12.95	20.05	21.07	24.30	25.97	25.51	24.94	26.27	7.55	6.87	7.89	7.94	2.27
Total Non-current Liabilities*	10.42	11.20	11.77	14.79	24.03	22.72	29.54	36.51	41.46	41.04	42.48	24.77	30.45	34.34	37.41	14.87
Total Liabilities	28.68	38.34	40.09	42.52	56.19	53.53	68.20	79.14	81.05	88.36	79.43	58.07	65.49	70.13	68.69	31.25
Retained Earnings	(338.51)	(350.77)	(351.39)	(335.55)	(347.56)	(345.86)	(325.14)	(299.96)	(270.83)	(260.63)	(194.60)	(184.64)	(112.09)	(90.55)	(90.63)	(98.50)
Total Stockholder Equity	372.23	353.74	347.16	352.62	325.46	321.44	333.41	332.02	352.13	358.11	408.25	412.31	478.52	489.26	452.28	208.78

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Total Revenue	27.50	18.79	28.07	25.42	23.94	(8.37)	30.57	28.33	31.73	32.73	33.33	39.51	37.70	44.26	40.75	40.53	36.22	37.31	33.80	31.20
Cost of Revenue	10.00	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Gross Profit	17.50	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Research & Development	2.65	(0.07)	2.71	2.72	2.20	(0.05)	2.05	2.38	3.53	4.40	5.40	4.84	4.15	4.16	3.43	3.43	3.78	3.57	3.22	3.05
Selling, General & Admin	12.21	10.55	12.07	11.40	11.50	5.36	11.35	10.89	12.93	12.97	12.51	15.40	14.84	13.54	11.58	11.35	11.20	10.39	10.08	7.15
Total Operating Expenses	17.47	--	--	--	16.02	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Operating Income	0.03	1.35	(0.09)	(16.64)	(1.22)	7.35	(1.56)	(2.79)	(10.13)	(13.16)	(28.78)	(15.28)	(13.60)	(50.24)	(11.40)	(76.26)	(7.63)	(17.24)	(11.16)	(4.55)
Pretax Income	1.25	3.36	0.70	(15.71)	(0.43)	7.54	(1.73)	(7.15)	(10.09)	(13.42)	(29.02)	(10.19)	(13.62)	(50.31)	(10.56)	(76.29)	(7.66)	(17.05)	(4.91)	(4.68)
Tax Provision	0.06	(0.17)	0.08	0.13	0.01	(0.14)	(0.03)	0.00	0.13	(0.04)	0.12	0.01	0.09	(0.08)	(0.60)	(3.74)	(0.60)	(2.58)	(4.99)	(12.55)
Net Income	1.19	11.07	0.62	(15.84)	(0.45)	12.46	(1.70)	(20.72)	(10.22)	(13.38)	(29.13)	(10.20)	(13.71)	(50.23)	(9.96)	(72.55)	(7.07)	(14.47)	0.08	7.88
Basic EPS	0.02	0.24	0.01	(0.33)	(0.01)	0.27	(0.04)	(0.45)	(0.22)	(0.30)	(0.67)	(0.23)	(0.32)	(1.18)	(0.23)	(1.71)	(0.17)	(0.37)	0.00	0.20
Diluted EPS	0.02	0.23	0.01	(0.33)	(0.01)	0.27	(0.04)	(0.45)	(0.22)	(0.30)	(0.67)	(0.23)	--	(1.18)	(0.23)	(1.71)	--	(0.36)	0.00	0.19

Cash Flow Statement

(in millions USD)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Operating Cash Flow	(0.49)	4.92	6.10	7.37	1.73	1.65	4.80	6.46	(4.47)	2.31	(4.38)	(7.72)	(2.71)	7.86	1.50	(9.92)	(7.92)	(0.77)	2.08	(7.72)
Capital Expenditures	0.17	--	--	--	--	--	--	--	--	0.98	1.50	0.61	3.30	4.45	2.45	2.04	1.46	1.57	2.41	2.69
Free Cash Flow*	(0.66)	--	--	--	--	--	--	--	--	1.33	(5.87)	(8.33)	(6.01)	3.41	(0.95)	(11.95)	(9.38)	(2.34)	(0.33)	(10.41)
Investing Cash Flow	(1.83)	1.14	(5.97)	(39.53)	(27.18)	73.64	(1.68)	(13.43)	(0.22)	3.96	1.66	9.29	2.93	(14.89)	(15.88)	(25.07)	(2.27)	(2.54)	(2.01)	(4.22)
Financing Cash Flow	(7.89)	(2.50)	(2.56)	(2.88)	(2.99)	(4.09)	(1.04)	(0.70)	(0.95)	9.84	0.61	0.70	(0.56)	(0.62)	17.41	(0.29)	(0.18)	(2.10)	(1.06)	(0.83)

* Derived from reported values